Arcelia Arrieta
Tolochenaz, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States.
Journal: Diabetes technology & therapeutics
Published: September 16, 2025
Automated insulin delivery with the MiniMed™ 780G system reduces burden by improving sleep and glycaemic control overnight.
Journal: Diabetes, obesity & metabolism
Published: September 03, 2025
Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26,427 Users.
Journal: Journal of diabetes science and technology
Published: March 12, 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targets.
Journal: Diabetes, obesity & metabolism
Published: December 09, 2024
Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care.
Journal: Journal of diabetes science and technology
Published: October 28, 2024
Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort.
Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort.
Journal: Diabetes research and clinical practice
Published: July 05, 2024
The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery.
Journal: Diabetes, obesity & metabolism
Published: June 18, 2024
Generating real-world evidence on diabetes technology using the CareLink Personal data management system.
Journal: Diabetes, obesity & metabolism
Published: June 12, 2024
MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias: Response to Inaccurate Allegations.
Journal: Diabetes technology & therapeutics
Published: April 02, 2024
Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience.
Journal: Diabetes technology & therapeutics
Published: March 06, 2024
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems.
Journal: Diabetes technology & therapeutics
Published: February 20, 2024
Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.
Journal: Diabetes technology & therapeutics
Published: February 20, 2024
Last Updated: 09/26/2026